These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14606586)

  • 1. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
    North PE; Mizeracki A; Mihm MC; Mrak RE
    Clin Neuropathol; 2000; 19(3):131-7. PubMed ID: 14606586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
    Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
    Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.
    Brown DF; Dababo MA; Hladik CL; Eagan KP; White CL; Rushing EJ
    Mod Pathol; 1998 Jan; 11(1):55-9. PubMed ID: 9556423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of spinal cord hemangioblastoma in von Hippel-Lindau disease].
    Nakashima H; Tokunaga K; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    No Shinkei Geka; 1999 Jun; 27(6):533-40. PubMed ID: 10396736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.
    Barresi V; Vitarelli E; Branca G; Antonelli M; Giangaspero F; Barresi G
    Am J Surg Pathol; 2012 Jul; 36(7):1052-7. PubMed ID: 22446946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
    Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
    PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas.
    Roy S; Chu A; Trojanowski JQ; Zhang PJ
    Acta Neuropathol; 2005 May; 109(5):497-502. PubMed ID: 15864611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease.
    Polydorides AD; Rosenblum MK; Edgar MA
    Arch Pathol Lab Med; 2007 Apr; 131(4):641-5. PubMed ID: 17425399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis of renal cell carcinoma to a haemangioblastoma of the medulla oblongata in von Hippel-Lindau syndrome.
    Xiong J; Chu SG; Wang Y; Zhu JJ; Li C; Mao Y
    J Clin Neurosci; 2010 Sep; 17(9):1213-5. PubMed ID: 20542433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma.
    Ingold B; Wild PJ; Nocito A; Amin MB; Storz M; Heppner FL; Moch H
    Histopathology; 2008 May; 52(6):674-81. PubMed ID: 18393979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral hemangioblastoma: clinicopathologic characterization in a series of 22 cases.
    Doyle LA; Fletcher CD
    Am J Surg Pathol; 2014 Jan; 38(1):119-27. PubMed ID: 24145646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Hippel-Lindau disease: a case report.
    Dave B; Patel V; Murthy AK; Khasgiwala R
    Indian J Pathol Microbiol; 2003 Jul; 46(3):482-3. PubMed ID: 15025317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
    Hoang MP; Amirkhan RH
    Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
    Ozcan A; Shen SS; Zhai QJ; Truong LD
    Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic hemangioblastoma of the kidney in a 29-year-old man.
    Wang CC; Wang SM; Liau JY
    Int J Surg Pathol; 2012 Oct; 20(5):519-22. PubMed ID: 22271882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.
    Cornford EM; Hyman S; Cornford ME; Landaw EM; Delgado-Escueta AV
    J Cereb Blood Flow Metab; 1998 Jan; 18(1):26-42. PubMed ID: 9428303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.
    Vortmeyer AO; Frank S; Jeong SY; Yuan K; Ikejiri B; Lee YS; Bhowmick D; Lonser RR; Smith R; Rodgers G; Oldfield EH; Zhuang Z
    Cancer Res; 2003 Nov; 63(21):7051-5. PubMed ID: 14612494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.